The foremost examples of BC biomarkers are the oestrogen receptor α (ERα or ER) and the human epidermal growth factor receptor 2 (HER2), which indicate differences in prognosis and predict responsiveness to endocrine and HER2-targeted therapies, respectively. Here, ERBB2 is linked to breast cancer.